Long-term exposures to low doses of silver nanoparticles enhanced in vitro malignant cell transformation in non-tumorigenic BEAS-2B cells

Toxicol In Vitro. 2016 Dec:37:41-49. doi: 10.1016/j.tiv.2016.09.003. Epub 2016 Sep 3.

Abstract

To predict carcinogenic potential of AgNPs on the respiratory system, BEAS-2B cells (human bronchial epithelial cells) were chronically exposed to low- and non-cytotoxic dose (0.13 and 1.33μg/ml) of AgNPs for 4months (#40 passages). To assess malignant cell transformation of chronic exposure to AgNPs, several bioassays including anchorage independent agar colony formation, cell migration/invasion assay, and epithelial-mesenchymal transition (EMT) were performed in BEAS-2B cells. Chronic exposure to AgNPs showed a significant increase of anchorage independent agar colony formation and cell migration/invasion. EMT, which is the loss of epithelial markers (E-Cadherin and Keratin) and the gain of mesenchymal marker (N-cadherin and Vimentin), was induced by chronic exposure to AgNPs. These responses indicated that chronic exposure to AgNPs could acquire characteristics of tumorigenic cells from normal BEAS-2B cells. In addition, caspase-3, p-p53, p-p38, and p-JNK were significantly decreased, while p-ERK1/2 was significantly increased. MMP-9 related to cell migration/invasion was upregulated, while a MMP-9 inhibitor, TIMP-1 was down-regulated. These results indicated that BEAS-2B cells exposed to AgNPs could induce anti-apoptotic response/anoikis resistance, and cell migration/invasion by complex regulation of MAPK kinase (p38, JNK, and ERK) and p53 signaling pathways. Therefore, we suggested that long-term exposure to low-dose of AgNPs could enhance malignant cell transformation in non-tumorigenic BEAS-2B cells. Our findings provide useful information needed to assess the carcinogenic potential of AgNPs.

Keywords: Apoptosis; BEAS-2B cells; Chronic exposure; Malignant cell transformation; Metastasis; Silver nanoparticles.

MeSH terms

  • Antigens, CD / metabolism
  • Cadherins / metabolism
  • Caspase 3 / genetics
  • Cell Line
  • Cell Movement / drug effects
  • Cell Survival / drug effects
  • Cell Transformation, Neoplastic / drug effects*
  • Epithelial-Mesenchymal Transition
  • Humans
  • Keratins / metabolism
  • Matrix Metalloproteinase 9 / metabolism
  • Metal Nanoparticles / toxicity*
  • Proto-Oncogene Proteins c-bcl-2 / genetics
  • RNA, Messenger / metabolism
  • Silver / toxicity*
  • Tissue Inhibitor of Metalloproteinase-1 / metabolism
  • Tumor Suppressor Protein p53 / genetics
  • Vimentin / metabolism
  • bcl-2-Associated X Protein / genetics

Substances

  • Antigens, CD
  • BAX protein, human
  • CDH1 protein, human
  • CDH2 protein, human
  • Cadherins
  • Proto-Oncogene Proteins c-bcl-2
  • RNA, Messenger
  • TIMP1 protein, human
  • Tissue Inhibitor of Metalloproteinase-1
  • Tumor Suppressor Protein p53
  • Vimentin
  • bcl-2-Associated X Protein
  • Silver
  • Keratins
  • Caspase 3
  • MMP9 protein, human
  • Matrix Metalloproteinase 9